Rapidly Ageing Population in Europe Boosts Prospects of Assisted Living Technologies Markets

An increasing ageing population and the associated need for healthcare services have heightened government attention on assisted living technologies, promoting the growth of this market in Europe. Early stages of technological and market development and limited awareness about the advantages of assisted living technologies threaten growth prospects. However, product customisation will help mitigate these challenges.

New analysis from Frost & Sullivan, European Markets for Assisted Living Technologies, finds that the markets earned revenues of $154.92 million in 2009 and estimates this to reach $525.58 million in 2015. The research closely examines assisted living devices for use in residences and institutions.

"A rapidly expanding elderly population in Europe is driving the need for continuous care, with mitigating this challenge featuring high on the agenda of governments in several European countries," notes Frost & Sullivan Research Analyst Somsainathan. "Governments are keen to address the needs of the elderly and provide the right social care to reduce the healthcare costs involved. Such trends are spurring the development of the market for assisted living technologies."

Rising awareness, coupled with the burgeoning need for assisted living technologies, are motivating market advancement. Participants are keen on capitalising on the end-user acceptance of these technologies and augmenting their shares in a market that is becoming increasingly competitive.

The market is developing at a brisk pace, surpassing the general healthcare industry average, mainly due to the spiralling demand for assisted living technologies. The increasing recognition of assisted living technologies is allowing participants to penetrate into the market with ease. Competition is intensifying rapidly, encouraging market participants to expand their geographic scope and improve their product portfolio.

However, high initial costs and shrinking budgets are the most important challenges for market participants. Similarly, the privacy and confidentiality issues involved have made end users reluctant to adopt such solutions.

"The high initial costs involved in setting up assisted living services have been paralleled by the post-recession phase which has led to shrinking healthcare budgets," explains Somsainathan. "Moreover, confidentiality and privacy issues in terms of data collected about end users have made many end users wary about adopting such technologies."

Product customisation and developing user-friendly technologies are key to boosting market penetration. A proper understanding of client needs will help design the right solutions, especially when the target client pool are the elderly who, in general, are sceptical of technological devices.

"Developing technologies that are user-friendly and marketable to the elderly population is critical to maintaining growth momentum," concludes Somsainathan. "Understanding client needs and ensuring product customisation based on this information will ensure success for assisted living technologies."

If you are interested in more information on Frost & Sullivan's latest study on European Markets for Assisted Living Technologies, please send an e-mail to Katja Feick, Corporate Communications, at This email address is being protected from spambots. You need JavaScript enabled to view it., with your full name, company name, title, telephone number, company e-mail address, company website, city, state and country.

European Markets for Assisted Living Technologies is part of the Patient Monitoring Growth Partnership Services programme, which also includes research in the following markets: Data Management Systems for Patient Monitoring Markets in Europe, European Market for non- Invasive Blood Pressure Monitors, European Telemetry Equipment Market and European Pulse Oximetry Market. All research included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants.

About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 40 offices on six continents. To join our Growth Partnership, please visit http://www.frost.com.

Most Popular Now

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...